Monday, 12 July, 2021 - 09:15
Wesfarmers makes bid for Priceline owner
Wesfarmers wants to buy Australian Pharmaceutical Industries, announcing today a $687 million offer for the business.
Australian Pharmaceutical Industries is an Australian health and beauty services company providing wholesale product delivery services, retail services, marketing programs and business advisory services to customers. API was acquired by Wesfarmers in 2021.
API also has as a number of brands and banners in the retail health and beauty industry including Priceline, Soul Pattinson and Pharmacist Advice.
API has three main businesses: pharmacy distribution, manufacturing and retail.
![]() |
NEWS: Tagged in Wesfarmers ups bid to acquire SILK | 26 Jun 2023 |
![]() |
NEWS: Tagged in API, Wesfarmers deal given shareholder nod | 17 Mar 2022 |
![]() |
NEWS: Tagged in ACCC clears Wesfarmers for API takeover | 11 Feb 2022 |
![]() |
NEWS: Tagged in Woolworths leaves Wesfarmers to chase API | 07 Jan 2022 |
![]() |
NEWS: Tagged in Wesfarmers digs heels on API bidding | 15 Dec 2021 |
![]() |
NEWS: Tagged in Woolworths' bid for API trumps Wesfarmers | 02 Dec 2021 |
![]() |
NEWS: Tagged in Wesfarmers wins takeover battle for API | 08 Nov 2021 |
Wesfarmers wants to buy Australian Pharmaceutical Industries, announcing today a $687 million offer for the business.
Priceline Pharmacy owner Australian Pharmaceutical Industries has rejected a takeover offer from Wesfarmers.
Wesfarmers looks like it may have sealed a takeover of Australian Pharmaceutical Industries (API) after an increased offer for all shares.
Wesfarmers has bolstered its chances of taking over Australian Pharmaceutical Industries after buying a 19.3 per cent stake.
Sigma Healthcare has withdrawn efforts to merge with Priceline owner Australian Pharmaceutical Industries leaving Wesfarmers to push ahead with a takeover.
Wesfarmers will make a foray into the health and beauty sector after winning the takeover battle with Sigma Healthcare for Priceline owner Australian Pharmaceutical Industries.
Woolworths has pitched an $872 million takeover offer for Australian Pharmaceutical Industries, pitting the retail giant against Wesfarmers.
Wesfarmers says it won’t accept any takeover offer made by Woolworths for API, as the retail giants fight for ownership of Australian Pharmaceutical Industries.
Woolworths Group has withdrawn its bid for Australian Pharmaceutical Industries (API), leaving Wesfarmers as the only suitor for the Priceline Pharmacy owner.
Australia’s competition regulator has given the all clear for Wesfarmers to acquire Australian Pharmaceutical Industries, a key condition needed to close the deal.
Wesfarmers is one step closer to completing its acquisition of Australian Pharmaceutical Industries after securing shareholder approval.
Wesfarmers' health and beauty division has upped its offer to $180 million to acquire SILK Laser Clinics after previously walking away from negotiations.
Name | Position | Year Started |
---|---|---|
Chief Executive, Managing Director
Group General Manager, Business Development & Operations (2005 to 2017) |
2017 | |
Company Secretary, General Counsel
|
2019 | |
Non-Executive Director
|
2020 | |
Non-Executive Director
|
2008 | |
Non-Executive Director, Chair since 2020
|
2014 | |
Non-Executive Director
|
2017 | |
Non-Executive Director
|
2020 | |
Non-Executive Director
|
2021 |
Name | Position | Year Started | Year Ended |
---|---|---|---|
Non-Executive Chairman, Non-Executive Director
|
2020 | ||
Non-Executive Director
|
2000 | 2020 | |
Chief Executive, Managing Director
|
2005 | 2017 | |
Group General Manager, Business Development & Operations
|
2005 | 2017 | |
Chief Financial Officer
|
2007 | 2008 | |
Non-Executive Director
|
2004 | 2007 | |
Alternate Director for John William Murphy
|
2007 | ||
Business Development Manager
|
2005 | 2007 | |
Non-Executive Director
|
2004 | ||
Managing Director
|
2000 | 2004 | |
Chairman
|
2003 | ||
Non-Executive Director
|
2003 | ||
Non-Executive Chairman, Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Non-Executive Director
|
|||
Group Leader
|
|||
Deputy Chairman
|
|||
Non-Executive Director
|
Announced | Bidder | Target | Transaction Type | Total Value | |
---|---|---|---|---|---|
Australian Pharmaceutical Industries, Wesfarmers | Acquisition | $135.00m | >> | ||
Australian Pharmaceutical Industries, Wesfarmers | SILK Laser Australia | Acquisition | $167.33m | >> | |
Wesfarmers | Australian Pharmaceutical Industries | Acquisition | $772.14m | >> |